Taenia crassiceps as a model for Taenia solium and the S3Pvac vaccine

Parasite Immunology

Volumn 33, Issue 1, 2011, Pages 79-80

  Sciutto, E ^a   Fragoso, G ^a   Larralde, C ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIGEN; S3PVAC VACCINE; UNCLASSIFIED DRUG; VACCINE;

CYSTICERCOSIS; DRUG EFFECT; HOST PARASITE INTERACTION; HUMAN; LETTER; NEUROCYSTICERCOSIS; NONHUMAN; PRIORITY JOURNAL; TAENIA CRASSICEPS; TAENIA SOLIUM;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYSTICERCOSIS; DISEASE MODELS, ANIMAL; EPITOPES; HOST-PARASITE INTERACTIONS; HUMANS; MICE; SPECIES SPECIFICITY; SWINE; TAENIA; TREATMENT OUTCOME; VACCINES, SYNTHETIC;

TAENIA CRASSICEPS; TAENIA SOLIUM;

EID: 78650053361     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01257.x     Document Type: Letter

References (7)

1. Lightowlers MW. Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine. Parasite Immunol (Accepted manuscript, DOI:).
2. Larralde C, Montoya RM, Sciutto E, et al. Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients. Am J Trop Med Hyg 1989; 40: 282-290.
3. Morales-Montor J & Larralde C. The role of sex steroids in the complex physiology of the host-parasite relationship: the case of the larval cestode of Taenia crassiceps. Parasitology 2005; 131: 287-294.
4. Willms K & Zurabian R. Taenia crassiceps: in vivo and in vitro models. Parasitology 2010; 137: 335-346.
5. Sciutto E, Rosas G, Hernández M, et al. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine 2007; 25: 1368-1378.
6. Segura-Velázquez R, Pérez-Torres A, Rosas-Salgado G, et al. A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine. Vaccine 2006; 24: 1073-1080.
7. Rassy D, Bobes RJ, Rosas G, et al. Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS ONE 2010; 5: e11287.